Familial breast cancer: an investigation into the outcome of treatment for early stage disease.
- 1 January 2001
- journal article
- Published by Springer Nature in Familial Cancer
- Vol. 1 (2) , 65-72
- https://doi.org/10.1023/a:1013867917101
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Germline BRCA1/2 Mutations and p27Kip1 Protein Levels Independently Predict Outcome After Breast CancerJournal of Clinical Oncology, 2000
- Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 MutationsJournal of Clinical Oncology, 2000
- Double-Strand Break Repair Deficiency and Radiation Sensitivity in BRCA2 Mutant Cancer CellsJNCI Journal of the National Cancer Institute, 1998
- BRCA1 mutations in southern England.British Journal of Cancer, 1998
- Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriersThe Lancet, 1998
- Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.1997
- A Mutation in Mouse rad51 Results in an Early Embryonic Lethal That Is Suppressed by a Mutation in p53Molecular and Cellular Biology, 1996
- Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.1995
- The prognostic significance of late local recurrence after breast-conserving therapyInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Cancer following medical irradiationCancer, 1981